Parenchyma-Sparing Pancreatic Surgery: Current Indications, Results, and Future Prospects
Cancers · 11.05.2026 · 18 (10) · 1550
DOI: 10.3390/cancers18101550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.05.2026. Verfasst von Silvio Caringi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Hepato-Biliary and Pancreatic Surgery, "F. Miulli" General Hospital, 70021 Acquaviva delle Fonti, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Parenchyma-sparing pancreatic surgery (PSPS) is a patient-centered alternative to traditional radical resections for benign and low-grade pancreatic lesions. Unlike pancreaticoduodenectomy and distal pancreatectomy, which tend to cause long-term exocrine and endocrine deficiency, PSPS aims to preserve functional tissue with a guarantee of oncologic safety. Techniques such as enucleation, central pancreatectomy, duodenum-preserving head resection, and uncinectomy are illustrative of this equipoise, with less risk of new-onset diabetes and malabsorption but more short-term morbidity in the form of postoperative pancreatic fistula. Advances in imaging technology, minimally invasive procedures, and robotics technology have extended PSPS indications beyond conventional candidates to thoughtfully selected neuroendocrine tumors, cystic neoplasms, and solid pseudopapillary neoplasms. Results are strongly dependent on patient selection, surgeon experience, and institutional volume, highlighting the importance of centralization and subspecialist training. While oncologic proficiency remains essential in aggressive tumors, evidence is in favor of PSPS being a curative and function-preserving option for properly screened patients with low-grade or benign conditions. Priorities for the future include multicenter prospective trials, optimization of perioperative techniques, and inclusion of patient-reported outcomes. PSPS represents a paradigm shift in pancreatic surgery, where technical innovation is balanced with quality of life in the long term and evolving principles of modern, individualized surgical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Hepato-Biliary and Pancreatic Surgery, "F. Miulli" General Hospital, 70021 Acquaviva delle Fonti, Italy.
- Department of Medicine and Surgery, LUM University, 70010 Casamassima, Italy.
- Transplant and HPB Unit, Department of Surgery Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.
ORCID-Profile: Antonella Delvecchio, Tommaso Maria Manzia, Michele Tedeschi, Riccardo Memeo
Zitieren
APA
Caringi, S., Delvecchio, A., Casella, A., Ferraro, V., Stasi, M., Tralli, N., Manzia, T. M., Tedeschi, M., & Memeo, R. (2026). Parenchyma-Sparing Pancreatic Surgery: Current Indications, Results, and Future Prospects. Cancers, 18(10), 1550. https://doi.org/10.3390/cancers18101550
Vancouver
Caringi S, Delvecchio A, Casella A, Ferraro V, Stasi M, Tralli N, et al. Parenchyma-Sparing Pancreatic Surgery: Current Indications, Results, and Future Prospects. Cancers. 2026;18(10):1550. doi:10.3390/cancers18101550
BibTeX
@article{Caringi2026,
author = {Caringi, Silvio and Delvecchio, Antonella and Casella, Annachiara and Ferraro, Valentina and Stasi, Matteo and Tralli, Nunzio and Manzia, Tommaso Maria and Tedeschi, Michele and Memeo, Riccardo},
title = {Parenchyma-Sparing Pancreatic Surgery: Current Indications, Results, and Future Prospects},
journal = {Cancers},
year = {2026},
volume = {18},
number = {10},
pages = {1550},
doi = {10.3390/cancers18101550}
}
EUVIMED